Malaria: from target identification and therapeutics [ 2005 - 2009 ]

Research Grant

Researchers: Prof Ross Coppel (Principal investigator) ,  Prof Brian Cooke ,  Prof Magdalena Plebanski ,  Prof Mark Von Itzstein

Brief description The team brings together a number of experts in various aspects of malaria, vaccines and drug design to develop new therapeutic approaches to control of one of the world�s major infectious diseases. Recent developments such as the complete sequence of every malaria gene provides an unparalleled opportunity to use a number of powerful new techniques in biology to identify vulnerabilities in the parasite that may be targeted. Members of the team include Professor von Itzstein who was responsible for the design of the anti-flu drug Relenza, Professor Ross Coppel who is a pioneer in the application of molecular biology to the study of malaria, and Drs Cooke and Plebanski, exciting and talented young scientists who already have made highly significant and important contributions to our understanding of how malaria parasites function and cause disease. Success in this research program has the capacity to save millions of lives each year by preventing the deadly toll of this important human scourge.

Funding Amount $AUD 5,276,440.20

Funding Scheme Programs

Notes Program Grant